By Sevita Verma Despite finding serious flaws in the controversial cervical cancer study in Gujarat and Andhra Pradesh, which was halted after some deaths, the committee investigating the matter has chosen to exonerate the wrong doers, say activists. The vaccination project on the human papilloma virus (HPV) was carried out among girls in the age […]
Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
BLUE BELL, Pa., Mar. 7, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus (HPV). […]
VRM: The Problem With Vaccines Part 3 – Synthetic Genomics & The Death Of Natural Immunity
By Joel Lord For centuries humankind has depended on an inherent natural immunity to survive; adapting to environmental changes while overcoming mutable diseases, viruses, bacterial or biological threats & inter-species cross contamination. With the 21st Century advancement of high-tech laboratory science (coupled with the unlimited finances of the Military Industrial Complex, Corporations & Governments in […]
Freda Birrell writes to Parliament
Freda Birrel, Secretary of SaneVax Inc., sent the following letter to Peter Bottomley, member of Parliament in the United Kingdom. She expresses her concern over misleading information put forth by health authorities and pharmaceutical companies regarding HPV vaccines. As always, the benefits appear to be overstated while potential risks are understated. Here is what she […]
Pneumonia Vaccine Approved as Deaths Mount During Trial
Gaia Health The vaccine trial is ongoing in Argentina. Parents agreed under threats of losing their children and without informed consent. GSK says it’s not the vaccine—but where’s the proof? by Heidi Stevenson 6 March 2011 As deaths were mounting from GlaxoSmithKline’s ongoing vaccine study in Argentina, the European Union’s Medicine Agency, EMEA, approved it […]
- « Previous Page
- 1
- …
- 356
- 357
- 358
- 359
- 360
- …
- 575
- Next Page »
